Does Wegovy start working instantly, or does it take time to kick in?

The decision most people are actually making: "Is it working yet, or should I stop?"

This is the question our prescribers hear regularly. Someone is two or three weeks into their first pen, the scales haven't moved, and they're wondering whether the treatment has failed or whether they were sold a fantasy. Neither, usually.

The most common misconception is that Wegovy should produce visible results within days, the way a painkiller resolves a headache. It doesn't work that way. Semaglutide is a GLP-1 receptor agonist, it mimics a gut hormone involved in appetite signalling and slows how quickly food leaves the stomach. Those mechanisms take time to exert sustained influence, and the blood concentration of semaglutide only reaches a stable level after four to five weeks of weekly injections. Before that point, your dose is still climbing toward the level where appetite suppression becomes reliable.

The semaglutide treatment overview covers the full pharmacology, but the short version is this: the first pen is largely about tolerance, not transformation. Nausea and other gastrointestinal effects are most noticeable early on precisely because your system is still adjusting. That tends to settle. The appetite effect then tends to grow.

When people typically notice something changing

Research from the STEP 1 trial, published in the New England Journal of Medicine, followed participants for 68 weeks. Average weight loss at the 2.4 mg maintenance dose was around 15%. Crucially, that figure reflects cumulative progress across the full period, not a result that arrived early and then plateaued.

In practice, many people notice the first real shift somewhere between weeks four and eight, often described as a reduced interest in finishing a meal or less urgency around snacking. It is subtle at first. By the time the dose reaches 1.0 mg or 1.7 mg, the effect is usually clearer. Reaching the 2.4 mg maintenance dose (the level studied in STEP 1) takes several months under the standard titration schedule, with each step roughly four weeks apart per prescriber guidance.

If you are wondering whether Wegovy works instantly or takes longer to take effect, the honest answer is that it takes longer, and that is by design rather than a sign something has gone wrong. The timeline of when Wegovy starts working is more variable than the packaging implies, and that variability is normal. Weight loss of 5% or more within the first six months is a reasonable early indicator that the treatment is having an effect for you. If it isn't, that's a clinical conversation, not a reason to quietly continue or abruptly stop.

Factors that shape how quickly you respond

Starting weight matters. People with a higher BMI may see larger absolute changes earlier, though percentage loss tends to converge over time. Dose level is probably the biggest single factor, a 0.25 mg or 0.5 mg dose simply produces less appetite suppression than 2.4 mg, and that is by design rather than a sign the medicine isn't working.

Diet and activity during treatment also influence the speed of response. Wegovy is licensed alongside a reduced-calorie diet and increased physical activity, and the trial evidence reflects that combination. The medicine makes it easier to eat less; it doesn't replace the eating less. Protein intake, hydration and not confusing rapid GI weight changes with fat loss in the early weeks are all worth understanding, our treatment overview page covers the lifestyle context in more detail.

Sleep, stress and other medicines can all affect weight during treatment in ways that are unrelated to whether semaglutide is working. If your progress feels unclear, the most common patient questions are a useful starting point before contacting the clinical team.

For context on what running costs look like over a course of treatment, the Wegovy price comparison page breaks down what's typically included and what isn't across different providers.

What the NHS and NICE say about gauging response

NICE guidance on semaglutide (Wegovy) recommends reviewing whether treatment should continue if weight loss falls below 5% after six months on the maintenance dose. That six-month window reflects the clinical consensus that the medicine needs time to work and that early weeks are not a fair measure of long-term response. Understanding what happens when Wegovy starts working can help you recognise early signs of progress that might otherwise be easy to dismiss. The NHS semaglutide medicines page sets out what to expect and when to speak to a healthcare professional.

Stopping without clinical advice because early results feel slow is one of the more common avoidable outcomes. If you are considering Wegovy through a regulated service, the right place to raise timing questions is with the prescriber reviewing your case, someone qualified to interpret your specific picture, not a general average.

Correct wegovy przechowywanie, meaning keeping your pens refrigerated and away from light, ensures the medicine remains effective throughout your treatment and that early results are not undermined by storage errors. If you'd like a clinical assessment of whether Wegovy is appropriate for you and to understand what a realistic timeline might look like, speak to our prescribers through a free consultation. A GPhC-registered Independent Prescriber reviews your case personally, every time.